Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,963 public trials 1,433 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

NCT06897930

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Santo André, São Paulo, Brazil
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 49 locations
View Trial Details
Recruiting

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

NCT06750185

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +28 more
Locations
  • Norton Cancer Institute PARENT Louisville, Kentucky, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Carolina BioOncology Institute, LLC Huntersville, North Carolina, United States
  • Rhode Island Hospital East Providence, Rhode Island, United States
View Trial Details
Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

NCT06994845

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Prim Childrens Hosp Inv Pharm Salt Lake City, Utah, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 20 locations
View Trial Details

Related conditions